Shares of Fate Therapeutics, Inc. (FATE) were in the spotlight on Monday morning after the company said that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced ...
Cellectar Biosciences (NASDAQ:CLRB) shares soared 27% after the company received Rare Pediatric Disease Designation from the U.S. Food and Drug Administration (FDA) for its iopofosine I 131 therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback